Blue nevi and variants: An update

Archives of Pathology and Laboratory Medicine

Volumn 135, Issue 3, 2011, Pages 327-336

  Zembowicz, Artur ^a,b,c,e   Phadke, Pushkar A ^d  

^a LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GNA11 PROTEIN, HUMAN; GNAQ PROTEIN, HUMAN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; TUMOR MARKER;

ARTICLE; BLUE NEVUS; FEMALE; GENETICS; HUMAN; MALE; MELANOCYTE; METABOLISM; MUTATION; PATHOLOGY; SKIN TUMOR;

FEMALE; GTP-BINDING PROTEIN ALPHA SUBUNITS; HUMANS; MALE; MELANOCYTES; MUTATION; NEVUS, BLUE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 79953009425     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. Murali R, McCarthy SW, Scolyer RA. Blue nevi and related lesions: a review highlighting atypical and newly described variants, distinguishing features and diagnostic pitfalls. Adv Anat Pathol. 2009; 16(6): 365-382.
2. Zembowicz A, Mihm MC. Dermal dendritic melanocytic proliferations: an update. Histopathology. 2004; 45(5): 433-451. (Pubitemid 39524318)
3. Tièche M. Über bénigne Melanome (Chromatophorome) der Haut- "blaue Naevi." Virchows Arch f path Anat. 1906; 1186: 212-229.
4. Bennaceur S, Fraitag S, Teillac-Hamel D, Bodemer C, Berdah S, ChretienMarquet B. Giant congenital blue nevus of the scalp [in French]. Ann Dermatol Venereol. 1996; 123(12): 807-810. (Pubitemid 27062080)
5. Fuchs F, Guillot E, Salama S, Vige P, Coulomb LA, Raynal P. Giant congenital scalp blue nevus, a neonatal case report. Eur J Obstet Gynecol Reprod Biol. 2007; 132(2): 243-244. (Pubitemid 46817709)
6. Kawasaki T, Tsuboi R, Ueki R, Fujioka N, lkeya T, Ogawa H. Congenital giant common blue nevus. J Am Acad Dermatol. 1993; 28(4): 653-654. (Pubitemid 23104248)
7. Dorsey CS, Montgomery H. Blue nevus and its distinction from Mongolian spot and the nevus of Ota. J Invest Dermatol. 1954; 22(3): 225-236.
8. Rodriguez HA, Ackerman LV. Cellular blue nevus: clinicopathologic study of forty-five cases. Cancer. 1968; 21(3): 393-405.
9. Temple-Camp CR, Saxe N, King H. Benign and malignant cellular blue nevus: a clinicopathological study of 30 cases. Am J Dermatopathol. 1988; 10(4): 289-296.
10. Buchner A, Leider AS, Merrell PW, Carpenter WM. Melanocytic nevi of the oral mucosa: a clinicopathologic study of 130 cases from northern California. J Oral Pathol Med. 1990; 19(5): 197-201. (Pubitemid 20333224)
11. Dohse L, Ferringer T. Nodal blue nevus: a pitfall in lymph node biopsies [published online ahead of print July 10, 2009]. J Cutan Pathol. doi:10.1111/ J.1600-0560.2009.01304.x.
12. Jiji V. Blue nevus of the endocervix: review of the literature. Arch Pathol Lab Med. 1971; 92(3): 203-205.
13. Mancini L, Gubinelli M, Fortunato C, Carella R. Blue nevus of the lymph node capsule: report of a case. Pathologica. 1992; 84(1092): 547-550.
14. Masci P, Ciardi A, Di TU. Blue nevus of the lymph node capsule. J Dermatol Surg Oncol. 1984; 10(8): 596-598. (Pubitemid 14055955)
15. Tannenbaum M. Differential diagnosis in uropathology, III-melanotic lesions of prostate: blue nevus and prostatic epithelial melanosis. Urology. 1974; 4(5): 617-621.
16. Rhodes AR, Silverman RA, Harrist TJ, Perez-Atayde AR. Mucocutaneous lentigines, cardiomucocutaneous myxomas, and multiple blue nevi: the "LAMB" syndrome. J Am Acad Dermatol. 1984; 10(1): 72-82. (Pubitemid 14222032)
17. Berti R, Inselvini E, Palvarini M, Crosti C. Agminate and plaque-type blue nevus combined with lentigo, associated with follicular cyst and eccrine changes: a variant of speckled lentiginous nevus. Dermatology. 1997; 195(4): 387-390. (Pubitemid 28017820)
18. Bondi EE, Elder D, Guerry D, Clark WH. Target blue nevus. Arch Dermatol. 1983; 119(11): 919-920. (Pubitemid 14230527)
19. Busam KJ, Woodruff JM, Erlandson RA, Brady MS. Large plaque-type blue nevus with subcutaneous cellular nodules. Am J Surg Pathol. 2000; 24(1): 92-99. (Pubitemid 30033401)
20. Hendricks WM. Eruptive blue nevi. J Am Acad Dermatol. 1981; 4(1): 50-53. (Pubitemid 11137316)
21. Krause MH, Bonnekoh B, Weisshaar E, Gollnick H. Coincidence of multiple, disseminated, tardive-eruptive blue nevi with cutis marmorata teleangiectatica congenita [review]. Dermatology. 2000; 200(2): 134-138. (Pubitemid 30199329)
22. Pittman JL, Fisher BK. Plaque-type blue nevus. Arch Dermatol. 1976; 112(8): 1127-1128.
23. van Leeuwen RL, Vink J, Bergman W, Herfst M, Bruijn JA. Agminate-type combined nevus consisting of a common blue nevus with a junctional Spitz nevus. Arch Dermatol. 1994; 130(8):1074-1075. (Pubitemid 24255049)
24. Walsh MY. Eruptive disseminated blue naevi of the scalp [comment]. Br J Dermatol. 1999;141(3):581-582. (Pubitemid 29448436)
25. Kang DS, Chung KY. Common blue naevus with satellite lesions: possible perivascular dissemination resulting in a clinical resemblance to malignant melanoma. Br J Dermatol. 1999; 141(5): 922-925.
26. Okun MR, Bhawan J. Combined melanocytoma-mastocytoma in a case of nodular mastocytosis. J Am Acad Dermatol. 1979; 1(4): 338-347.
27. Sun J, Morton TH Jr, Gown AM. Antibody HMB-45 identifies the cells of blue nevi: an immunohistochemical study on paraffin sections. Am J Surg Pathol. 1990; 14(8): 748-751. (Pubitemid 20233014)
28. Pulitzer DR, Martin PC, Cohen AP, Reed RJ. Histologic classification of the combined nevus: analysis of the variable expression of melanocytic nevi. Am J Surg Pathol. 1991; 15(12): 1111-1122.
29. Naylor EM, Ruben BS, Robinson-Bostom L, Telang GH, Jellinek NJ. Subungual blue nevus with combined phenotypic features. J Am Acad Dermatol. 2008; 58(6): 1021-1024. (Pubitemid 351657613)
30. Pozo L, Diaz-Cano SJ. Malignant deep sclerosing blue naevus presenting as a subcutaneous soft tissue mass. Br J Dermatol. 2004; 151(2): 508-511. (Pubitemid 39215172)
31. Rongioletti F, Innocenzi D. Sclerosing 'mucinous' blue naevus. Br J Dermatol. 2003; 148(6): 1250-1252.
32. Carlson JA, Dickersin GR, Sober AJ, Barnhill RL. Desmoplastic neurotropic melanoma: a clinicopathologic analysis of 28 cases. Cancer. 1995; 15; 75(2): 478-494.
33. Anstey A, Cerio R, Ramnarain N, Orchard G, Smith N, Jones EW. Desmoplastic malignant melanoma: an immunocytochemical study of 25 cases. Am J Dermatopathol. 1994; 16(1): 14-22. (Pubitemid 24062747)
34. Longacre TA, Egbert BM, Rouse RV. Desmoplastic and spindle-cell malignant melanoma: an immunohistochemical study. Am J Surg Pathol. 1996; 20(12): 1489-1500. (Pubitemid 26411717)
35. Skelton HG III, Smith KJ, Barrett TL, Lupton GP, Graham JH. HMB-45 staining in benign and malignant melanocytic lesions: a reflection of cellular activation. Am J Dermatopathol. 1991; 13(6): 543-550.
36. Wood WS, Tron VA. Analysis of HMB-45 immunoreactivity in common and cellular blue nevi. J Cutan Pathol. 1991; 18(4): 261-263.
37. Bhawan J, Cao SL. Amelanotic blue nevus: a variant of blue nevus. Am J Dermatopathol. 1999; 21 (3): 225-228. (Pubitemid 29256816)
38. Zembowicz A, Cranter SR, McKee PH, Mihm MC. Amelanotic cellular blue nevus: a hypopigmented variant of the cellular blue nevus: clinicopathologic analysis of 20 cases. Am J Surg Pathol. 2002; 26(11): 1493-1500. (Pubitemid 35239426)
39. Carney JA, Ferreiro JA. The epithelioid blue nevus: a multicentric familial tumor with important associations, including cardiac myxoma and psammomatous melanotic schwannoma. Am J Surg Pathol. 1996; 20(3): 259-272. (Pubitemid 26071506)
40. Zembowicz A. Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol. 2004; 28(1): 31-40. (Pubitemid 38031618)
41. Mandai RV, Murali R, Lundquist KF, et al. Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol. 2009; 33(12): 1778-1782.
42. Zembowicz A, Knoepp SM, Bei T, et al. Loss of expression of protein kinase a regulatory subunit 1 alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol. 2007; 31(11): 1764-1775. (Pubitemid 350287576)
43. Seab JA Jr, Graham JH, Helwig EB. Deep penetrating nevus. Am J Surg Pathol. 1989; 13(1): 39-44. (Pubitemid 19015528)
44. Allen AC, Spitz S. Malignant melanoma; a clinicopathological analysis of the criteria for diagnosis and prognosis. Cancer. 1953; 6(1): 1-45.
45. Allen AC. A reorientation on the histogenesis and clinical significance of cutaneous nevi and melanomas. Cancer. 1949; 2(1): 28-56.
46. Speakman JS, Phillips MJ. Cellular and malignant blue nevus complicating oculodermal melanosis (nevus of Ota syndrome). Can J Ophthalmol. 1973; 8(4): 539-547.
47. Causeret AS, Skowron F, Viallard AM, Balme B, Thomas L. Subungual blue nevus. J Am Acad Dermatol. 2003; 49(2): 310-312. (Pubitemid 36951286)
48. Michal M, Baumruk L, Skalova A. Myxoid change within cellular blue naevi: a diagnostic pitfall. Histopathology. 1992; 20(6): 527-530.
49. Biernat W, Kordek R, Wozniak L. Cellular blue nevi with myxoid change-diagnostic difficulties and the review of the literature. Pol J Pathol. 1995; 46(2): 83-86.
50. Smith K, Germain M, Williams J, Skelton H. CD34-positive cellular blue nevi. J Cutan Pathol. 2001; 28(3): 145-150. (Pubitemid 32113000)
51. Avidor I, Kessler E. 'Atypical' blue nevus-a benign variant of cellular blue nevus: presentation of three cases. Dermatológica. 1977; 154(1): 39-44. (Pubitemid 8061310)
52. Tran TA, Carlson JA, Basaca PC, Mihm MC. Cellular blue nevus with atypia (atypical cellular blue nevus): a clinicopathologic study of nine cases. J Cutan Pathol. 1998; 25(5): 252-258. (Pubitemid 28306514)
53. Maize JC Jr, McCalmont TH, Carlson JA, Busam KJ, Kutzner H, Bastian BC. Genomic analysis of blue nevi and related dermal melanocytic proliferations. Am J Surg Pathol. 2005; 29(9): 1214-1220. (Pubitemid 41232995)
54. Barnhill RL, Argenyi Z, Berwick M, et al. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol. 2008; 32(1): 36-44.
55. Epstein JI, Erlandson RA, Rosen PP. Nodal blue nevi: a study of three cases. Am J Surg Pathol. 1984; 8(12): 907-915. (Pubitemid 15161466)
56. Lamovec J. Blue nevus of the lymph node capsule: report of a new case with review of the literature. Am J Clin Pathol. 1984; 81 (3): 367-372. (Pubitemid 14156010)
57. Sterchi JM, Muss HB, Weidner N. Cellular blue nevus simulating metastatic melanoma: report of an unusually large lesion associated with nevus-cell aggregates in regional lymph nodes.) Surg Oncol. 1987; 36(1): 71-75. (Pubitemid 17139550)
58. Pich A, Chiusa L, Margaria E, Aloi F. Proliferative activity in the malignant cellular blue nevus. Hum Pathol. 1993; 24(12): 1323-1329. (Pubitemid 24033735)
59. Prieto VG, Shea CR. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol. 2008; 35(suppl 2): 1-10.
60. Wang Q, Prieto V, Esmaeli B, et al. Cellular blue nevi of the eyelid: a possible diagnostic pitfall. J Am Acad Dermatol. 2008; 58(2): 257-260.
61. Aloi F, Pich A, Pippione M. Malignant cellular blue nevus: a clinicopathological study of 6 cases. Dermatology. 1996; 192(1): 36-40.
62. Boi S, Barbareschi M, Vigi E, Cristofolini M. Malignant blue nevus : report of four new cases and review of the literature. Histol Histopathol. 1991; 6(3): 427-434.
63. Connelly J, Smith JL Jr. Malignant blue nevus. Cancer. 1991; 67(10): 2653-2657.
64. Duteille F, Duport G, Larregue M, Neau A, Duriez P, Herve MC. Malignant blue nevus: three new cases and a review of the literature. Ann Plast Surg. 1998; 41(6): 674-678. (Pubitemid 29005660)
65. Fisher ER. Malignant blue nevus. AMA Arch Derm. 1956; 74(3): 227-231.
66. Goldenhersh MA, Savin RC, Barnhill RL, Stenn KS. Malignant blue nevus: case report and literature review. J Am Acad Dermatol. 1988; 19(4): 712-722.
67. Martin RC, Murali R, Scolyer RA, Fitzgerald P, Colman MH, Thompson JF. So-called "malignant blue nevus": a clinicopathologic study of 23 patients. Cancer. 2009; 115(13): 2949-2955.
68. Mehregan DA, Gibson LE, Mehregan AH. Malignant blue nevus: a report of eight cases. J Dermatol Sci. 1992; 4(3): 185-192. (Pubitemid 23017816)
69. Leopold JG, Richards DB. The interrelationship of blue and common naevi. J Pathol Bacteriol. 1968; 95(1): 37-46.
70. Zimmermann AA, Cornbleet T. The development of epidermal pigmentation in the Negro fetus.; Invest Dermatol. 1948; 11(5): 383-395.
71. Hori Y, Kawashima M, Oohara K, Kukita A. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol. 1984; 10(6): 961-964. (Pubitemid 14117358)
72. Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Palier AS, Leffell DJ. Fitzpatrick's Dermatology in General Medicine. 7th ed. Columbus, OH: McGraw-Hill Professional; 2007.
73. Kazakov DV, Michal M. Melanocytic "ball-in-mitts" and "microalveolar structures" and their role in the development of cellular blue nevi. Ann Diagn Pathol. 2007; 11(3): 160-175. (Pubitemid 46694381)
74. Kunachak S, Kunachakr S, Sirikulchayanonta V, Leelaudomniti P. Dermabrasion is an effective treatment for acquired bilateral nevus of Ota-like macules. Dermatol Surg. 1996; 22(6): 559-562. (Pubitemid 26200113)
75. Rubin Al, Laborde SV, Stiller MJ. Acquired dermal melanocytosis: appearance during pregnancy. I Am Acad Dermatol. 2001; 45(4): 609-613. (Pubitemid 32917260)
76. Van Raamsdonk CD, Fitch KR, Fuchs H, de Angelis MH, Barsh GS. Effects of G-protein mutations on skin color. Nat Genet. 2004; 36(9): 961-968. (Pubitemid 39167492)
77. Singh AD, De PP, Fijal BA, Shields CL, Shields JA, Elston RC. Lifetime prevalence of uveal melanoma in white patients with oculo(dermal) melanocytosis. Ophthalmology. 1998; 105 (1): 195-198. (Pubitemid 28070622)
78. Van Raamsdonk CD, Bezrookove V, Green G, et al. Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi. Nature. 2009; 457(7229): 599-602.
79. Kunisada T, Yamazaki H, Hirobe T, et al. Keratinocyte expression of transgenic hepatocyte growth factor affects melanocyte development, leading to dermal melanocytosis. Mech Dev. 2000; 94(1-2): 67-78. (Pubitemid 30332389)
80. Broome PM, Gause PR, Hyman P, et al. Induction of melanoma in TPras transgenic mice. Carcinogenesis. 1999; 20(9): 1747-1753. (Pubitemid 29410554)
81. Pollock PM, Harper UL, Hansen KS, et al. High frequency of BRAF mutations in nevi. Nat Genet. 2003; 33(1): 19-20. (Pubitemid 36068675)
82. Albino AP, Nanus DM, Mentle IR, et al. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene. 1989; 4(11): 1363-1374. (Pubitemid 19273392)
83. Omholt K, Karsberg S, Platz A, Kanter L, Ringborg U, Hansson J. Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression. Clin Cancer Res. 2002; 8(11): 3468-3474. (Pubitemid 35340723)
84. Saldanha G, Purnell D, Fletcher A, Potter L, Gillies A, Pringle JH. High BRAF mutation frequency does not characterize all melanocytic tumor types. Int J Cancer. 2004; 111 (5): 705-710. (Pubitemid 39062892)
85. Yazdi AS, Palmedo G, Flaig MJ, et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J Invest Dermatol. 2003; 121(5): 1160-1162. (Pubitemid 37430987)
86. Ohashi A, Funasaka Y, Ueda M, Ichihashi M. c-KIT receptor expression in cutaneous malignant melanoma and benign melanotic naevi. Melanoma Res. 1996; 6(1): 25-30. (Pubitemid 26065018)